PDE4D and neurodegenerative disease: Conversely, a depletion of cAMP levels induced by the high expression of PDE4D subtypes D1 and D3 was observed in neurodegenerative diseases (e.g., AD) and associated with cognitive deterioration and neuroinflammation [53].